OncLive: Dr. Mesa on recent data with momelotinib in MPNs and myelofibrosis

Ruben Mesa, MD, director of the Mays Cancer Center, discusses recent data with momelotinib in myelofibrosis.

Read and watch the story.



Share This Article!